/PRNewswire/ With the approvals of GlaxoSmithKline s Benlysta (belimumab) in lupus nephritis (LN) at the end of 2020 and Aurinia s Lupkynis (voclosporin) at.
/PRNewswire/ Rheumatologists have long struggled to effectively treat patients with systemic lupus erythematosus (SLE) given the wide heterogeneity of the.